Foreign-born hispanics have survival advantage in NSCLC

Foreign-born hispanics have survival advantage in NSCLC
Compared with non-Hispanic whites and U.S.-born Hispanics, foreign-born Hispanics with non-small-cell lung cancer have a reduced risk of disease-specific mortality, according to research published online Aug. 19 in the Journal of Clinical Oncology.

(HealthDay)—Compared with non-Hispanic whites (NHWs) and U.S.-born Hispanics, foreign-born Hispanics with non-small-cell lung cancer (NSCLC) have a reduced risk of disease-specific mortality, according to research published online Aug. 19 in the Journal of Clinical Oncology.

Manali I. Patel, M.D., of Stanford University in California, and colleagues conducted a of data for 1998 to 2007 from the California Cancer Registry (with follow-up through 2009) for NHWs and 14,280 Hispanics with NSCLC to assess individual, clinical, and neighborhood factors in survival.

The researchers found a significantly lower risk of disease-specific mortality related to NSCLC in foreign-born Hispanics, compared with NHWs (hazard ratio [HR], 0.85) after adjustment for individual, clinical, and neighborhood factors, and compared with U.S.-born Hispanics (HR, 0.90) after adjustment for individual factors. Foreign-born Hispanics who lived in low socioeconomic and high Hispanic enclave neighborhoods had a compared with U.S.-born Hispanics.

"In conclusion, despite advanced stage at diagnosis, lower likelihood of treatment, and greater likelihood of living in low socioeconomic status neighborhoods, foreign-born Hispanics had improved survival after NSCLC than U.S.-born Hispanics and NHWs," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Experts set strategic priorities for lymphoma research

date 10 hours ago

A committee of lymphoma experts today unveiled a strategic roadmap identifying key priority areas in both infrastructure and research that will be critical for advancing treatments for people with lymphoma. The report is meant to inform future research directions as well as fund ...

Research aims to reduce health care disparities

date 10 hours ago

The lesbian, gay, bisexual, transgender/transsexual, queer/questioning and intersex (LGBTQI) population has been largely understudied by the medical community. Researchers at Moffitt Cancer Center found that the LGBTQI community ...

Promising drug target identified in medulloblastoma

date 12 hours ago

Scientists at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have identified a protein critical to both the normal development of the brain and, in many cases, the development of medulloblastoma, a fast-growing ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.